Illumina Cuts 51 Jobs at San Diego Headquarters
The layoffs follow nearly 300 position eliminations in 2025 and pressure from federal research funding cuts and tariffs.
Updated on Nov. 16, 2026 in Biotech

Live Poll
Do you trust large local employers to keep their workforces stable?
Illumina plans to lay off 51 employees at its San Diego headquarters at 5200 Illumina Way, affecting managerial roles, lab technicians, engineers and scientists. The company filed a WARN notice with the state regarding the cuts.
Why it matters
The reductions add to a wider restructuring after Illumina eliminated nearly 300 positions in 2025 under a $100 million cost-cutting initiative. The company cited financial pressures from federal research funding cuts and tariffs, and it faces trade restrictions from China's Unreliable Entity List designation.
Illumina's third-quarter sales reached $1.13 billion, a 4.16% year-over-year increase, with profit of $220 million up 47% from the prior year. The company has not broken down its headcount by facility, so the full scope of positions affected beyond San Diego remains unclear.
The players
Illumina
Illumina is a San Diego-based genomics company that makes DNA sequencing instruments and reagents used in research and clinical testing.
The details
The cuts span managerial positions, lab technicians, engineers and scientists and will take effect in stages from Nov. 9 through Jan. 8. China accounted for roughly 10% of Illumina's revenue in 2022 and brought in $59 million, or 5% of sales, last quarter.
Timeline
2025: Illumina eliminated nearly 300 positions and enacted a $100 million cost-cutting initiative.
Early 2025: Beijing blacklisted Illumina.
Oct. 30, 2026: Illumina reported third-quarter earnings.
Nov. 9, 2026 through Jan. 8, 2027: Layoff period at the San Diego headquarters.
Tech Race
The cuts reflect pressure from reduced federal research budgets, which have squeezed demand for lab sequencing equipment that Illumina sells to academic and government laboratories. The company is now trying to maintain margins while competing in a market shaped by trade restrictions and cost pressure.
Employees in managerial, laboratory, engineering and scientific roles at the San Diego headquarters face job loss during the November through January window. Customers of Illumina's sequencing products may see changes in service and support as the company trims staff.
The takeaway
Biotech employers can shift quickly when federal research funding and trade rules change, so workers in the sector should watch quarterly filings and WARN notices closely. Customers relying on sequencing vendors should confirm support contacts before major projects.
What happens next
Illumina's layoffs are scheduled to take effect in stages between Nov. 9, 2026 and Jan. 8, 2027.
Further reading
Explore more San Diego biotech news for context on the region's life-science employers.
Source note: This article includes information reported by San Diego Union-Tribune.
Live Poll
Do you trust large local employers to keep their workforces stable?






